Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA's and FDA's Views on Initial Dual-Therapy.
Therapeutic Innovation & Regulatory Science（2020）
Key words
regulatory approval,regulatory science,prescription drug labeling,therapeutic indication,add-on therapy,substitution therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined